Volume 61, Issue 1, Pages (January 2002)

Slides:



Advertisements
Similar presentations
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Advertisements

Michael Allon, Michelle L. Robbin  Kidney International 
When Using DOPPS Slides
Volume 77, Issue 12, Pages (June 2010)
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization  Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,
Mae Thamer, Timmy C. Lee, Haimanot Wasse, Marc H
Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.
In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’  Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.
Volume 63, Issue 1, Pages (January 2003)
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients  G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,
Volume 64, Pages S3-S12 (December 2003)
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Vascular access in hemodialysis patients older than 80 years
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Volume 64, Issue 3, Pages (September 2003)
Type of vascular access and mortality in U.S. hemodialysis patients
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice.
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Volume 85, Issue 1, Pages (January 2014)
Volume 57, Pages S74-S81 (January 2000)
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Satinderjit Locham, Apurva B
A practical approach to vascular access for hemodialysis and predictors of success  Peter G. Kalman, MD, Mark Pope, MD, Cyndi Bhola, RN, Robert Richardson,
Survival advantage in Asian American end-stage renal disease patients1
Volume 68, Issue 5, Pages (November 2005)
Volume 77, Issue 7, Pages (April 2010)
Volume 77, Issue 2, Pages (January 2010)
Volume 82, Issue 5, Pages (September 2012)
Hark Rim, Ho S. Shin, Yeon S. Jung
The epidemiology of chronic kidney disease
Stephen P. McDonald  Kidney International Supplements 
Volume 62, Issue 6, Pages (December 2002)
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
Body size and outcomes on peritoneal dialysis in the United States
Michael D. Sgroi, MD, Madhukar S. Patel, MD, Samuel E
Volume 85, Issue 1, Pages (January 2014)
Volume 65, Issue 6, Pages (June 2004)
Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD 
Volume 66, Issue 5, Pages (November 2004)
Volume 62, Issue 5, Pages (November 2002)
Volume 70, Issue 10, Pages (November 2006)
Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower 
Volume 83, Issue 2, Pages (February 2013)
Cardiovascular disease in pediatric chronic dialysis patients
Volume 64, Issue 1, Pages (July 2003)
David A. Goodkin, MD, Eric W
Volume 68, Issue 1, Pages (July 2005)
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 82, Issue 3, Pages (August 2012)
Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients  Finnian R. Mc Causland, Sushrut S.
Volume 63, Issue 6, Pages (June 2003)
Volume 95, Issue 4, Pages (April 2019)
Volume 65, Issue 6, Pages (June 2004)
Volume 70, Issue 8, Pages (October 2006)
Volume 66, Issue 6, Pages (December 2004)
Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M
Long-term outcome of dialysis patients in the United States with coronary revascularization procedures  Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.
Volume 64, Issue 5, Pages (November 2003)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Creating functional autogenous vascular access in older patients
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 61, Issue 2, Pages (February 2002)
Volume 77, Issue 12, Pages (June 2010)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists  Gerald A. Beathard, Terry Litchfield  Kidney.
Distribution of vascular access type (2002–2011) among countries with stable or decreasing catheter burden over time. Distribution of vascular access type.
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation  Theodore.
Presentation transcript:

Volume 61, Issue 1, Pages 305-316 (January 2002) Vascular access use in Europe and the United States: Results from the DOPPS  Ronald L. Pisoni, Ph.D., Eric W. Young, Dawn M. Dykstra, Roger N. Greenwood, Erwin Hecking, Brenda Gillespie, Robert A. Wolfe, David A. Goodkin, Philip J. Held  Kidney International  Volume 61, Issue 1, Pages 305-316 (January 2002) DOI: 10.1046/j.1523-1755.2002.00117.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Arteriovenous fistula (AVF) use among prevalent patients in Europe (EUR) and the United States (US) for patient groups (A) without diabetes, peripheral vascular disease, (PVD), and coronary artery disease (CAD). (B) Patients with diabetes, PVD, and/or CAD. The percent of patients using an AVF at the time of study enrollment in a cross-sectional sample of patients was determined for the two subgroups shown. Kidney International 2002 61, 305-316DOI: (10.1046/j.1523-1755.2002.00117.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Distribution of arteriovenous fistula (AVF) use among facilities within Europe (EUR) and the United States (US). The percent of patients using an AVF was determined for a cross-sectional sample of patients within each DOPPS dialysis unit in EUR and the US. The distribution of AVF use within facilities is shown separately for the US (—) and EUR (- - - ), and is shown in increments of 5%. The following percentiles of each distribution are provided for the 10th, 25th, 50th (median), 75th, and 90th percentiles. Kidney International 2002 61, 305-316DOI: (10.1046/j.1523-1755.2002.00117.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Arteriovenous fistula (AVF) use among incident patients in Europe (EUR) and the United States (US) for three different patient groups. The percent of white patients, who were new to HD and using an AVF at study start was determined for the three groups. Values of n refer to the total number of patients in the particular subgroup. Kidney International 2002 61, 305-316DOI: (10.1046/j.1523-1755.2002.00117.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 (A) Survival function of arteriovenous fistula (AVF) versus graft survival in United States (US) and Europe (EUR) for incident patients using a permanent vascular access at study start. Access survival estimates were obtained from Cox regression analysis stratified by access type, and adjusted for patient age, gender, diabetes mellitus, peripheral vascular disease, and body mass index (N = 430 for EUR, N = 428 for US). The small number of grafts among EUR incident patients precluded a survival analysis for grafts in EUR. (B) Survival function of AVF versus graft survival in US and EUR for incident patients starting HD with a temporary vascular access. Analysis is restricted to incident patients starting HD with a temporary access but focuses upon survival of the first permanent access used by the patient thereafter. Access survival estimates were obtained from Cox regression analysis stratified by access type, and adjusted for patient age, gender, diabetes mellitus, peripheral vascular disease, and body mass index (N = 164 for EUR, N = 209 for US). The small number of grafts among EUR incident patients precluded a survival analysis for grafts in EUR. Kidney International 2002 61, 305-316DOI: (10.1046/j.1523-1755.2002.00117.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 (A) Distribution of placement locations for untunneled temporary catheters used by incident patients at start of hemodialysis (HD) in Europe (EUR) and the United States (US). (N = 204 for EUR, N = 628 for US). (B) Distribution of placement locations of tunneled central vein catheters used by incident patients at start of HD in EUR and the US. (N = 71 for EUR, N = 683 for US). Kidney International 2002 61, 305-316DOI: (10.1046/j.1523-1755.2002.00117.x) Copyright © 2002 International Society of Nephrology Terms and Conditions